pulseadmin
Mankind Pharma net profit dropped 16% YoY to Rs 385 crore in Q3FY25 led by higher expenses. The company reported revenue from operations at Rs. 3,230 Cr, up by 24% YoY.
The adjusted EBITDA rose 46% YoY to Rs 895 crore. Adjusted EBITDA margin of 26.9% up by 210 bps YoY.
Domestic revenue at Rs 2773…
GIPHY App Key not set. Please check settings